MIP Search | Managing Intellectual Property

Knowledge is a tricky business

It is a challenge for firms to stay ahead in the KPO business. Savi Gupta of Clairvolex, New Delhi, outlines how to succeed

Managing IP Correspondent, June 30 2008

EPO Enlarged Board to consider dosage regimen claims

It is persistent European Patent Office (EPO) case law that, while therapeutic methods are excluded from patentability, not only a claim to a known substance for its first medical use, but also for its second medical use (that is, its use in the therapy of a different disease) is patentable (G 5/83). There is, however, a dispute over whether a mere change in dosage regimen configures a patentable second medical use even when the medicament and disease remain unchanged.

Managing IP Correspondent, June 30 2008

IP standards implemented

Prepared by SIPO and promulgated by the State Quality & Quarantine Supervision and Standardization Administration Committee, two standards concerning IP documentation and information came into force on June 1 2008.

Managing IP Correspondent, June 30 2008

Fighting IP crime

The civil Chilean police have recently created a special division called the Investigative Brigade of Crimes against Intellectual Property (BRIDEPI).

Managing IP Correspondent, June 30 2008

The effects of DR-CAFTA on IP

The Free Trade Agreement between the Dominican Republic, Central America and United States of America (DR-CAFTA) has resulted in improved intellectual property legislation in Central America, which will require substantial modifications to the existing legal frameworks in the region. The agreement will enhance intellectual property protection by harmonizing domestic and international IP laws. All DR-CAFTA parties have agreed to enter certain treaties, as well as to make reasonable efforts to enter others.

Managing IP Correspondent, June 30 2008

Biotechnology patent prosecution under review

In late 2007, the Canadian Intellectual Property Office (CIPO) published a draft update to Chapter 17 of the Manual of Patent Office Practice (MOPOP). In response, the Intellectual Property Institute of Canada (IPIC) made a thorough submission for CIPO's consideration.

Managing IP Correspondent, June 30 2008

Lipitor patent invalidated on appeal

The Full Court of the Federal Court recently upheld the trial judge's invalidation of one of the Lipitor patents for false suggestion or misrepresentation.

Managing IP Correspondent, June 30 2008

Recent developments regarding personal data

At present, personal data and data privacy are governed and protected in Argentina by Law 25,326 (Personal Data Protection Act). This article summarizes the main provisions of the Act, and at the same time highlights recent legal developments related to the National Registry of Databases.

Managing IP Correspondent, June 30 2008

Prepare for the domain name explosion

Are you ready for a world with 500 top-level domains? You should be. James Nurton reports from the ICANN meeting in Paris

Managing IP Correspondent, June 30 2008

Lipitor dispute settled

Branded and generic drugs companies could be more willing to compromise on IP rights, following the Pfizer/Ranbaxy settlement over Lipitor

Managing IP Correspondent, June 30 2008

Search results for